We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Speaker: Dr. Cristina Ugalde Bilbao, scientist at the CSIC, where she will continue to develop her interests in mitochondrial translational research.
The structural organization of the mitochondrial respiratory chain (MRC) has been intensely debated for over 60 years. The mammalian MRC is formed by complexes I, III and IV that can associate in supercomplexes (SCs) and respirasomes,whose biogenetic regulation and functional properties remain unclear. We have shown the coexistence of two separated MRC organizations in human cells and postmitotic tissues, C-MRC and S-MRC, defined by the preferential expression of each of the three complex IV COX7A subunit isoforms: COX7A1, COX7A2 and COX7A2L (SCAFI). Notably, prevalence of each MRC organization is reversibly regulated by the activation state of the pyruvate dehydrogenase complex (PDC). Activated PDC promotes oxidative phosphorylation (OXPHOS) where the C-MRC organization is prevalent, whereas inactivated PDC stimulates the S-MRC organization upon metabolic rewiring of OXPHOS towards glycolysis. We show a link between the metabolic signatures converging at PDC and the structural and functional organization of the MRC, concluding that its structural heterogeneity warrants optimal adaptation to metabolic function.
CV: Her research work focuses on the study of mitochondrial pathologies, specifically on the molecular mechanisms that regulate the biogenesis and function of the mitochondrial OXPHOS system in human cells and tissues in health and disease conditions. She has extensive experience in the translational application of genetic-molecular and biochemical-proteomic techniques, as well as in the concepts of medicine, metabolism and mitochondrial bioenergetics, with a clearly translational orientation into the diagnosis and treatment of mitochondrial pathologies.
Cristina spent a 4-year postdoctoral period at the Laboratory of Mitochondrial Disorders at the Radboud University Medical Center (Nijmegen, The Netherlands), supervised by Profs. Leo Nijtmans and Jan Smeitink. In 2005, she became a Principal Investigator (PI) of the Miguel Servet Program and joined the Laboratory of Rare, Mitochondrial and Neuromuscular Diseases (LERMN) at Hospital 12 de Octubre Research Institute (i+12, Madrid). She belongs to the CIBER for Rare Diseases (CIBERER) since 2006 and in 2011, she became an I3 Researcher of the National Health System. In 2018, she spent a sabbatical year as Guest Researcher at Prof. Mike Ryan´s lab (Monash University, Australia) in order to acquire new skills on CRISPR/Cas9 genome editing and functional proteomics. In 2023, she got a tenured scientist position at CSIC, where she will continue developing her scientific interests on mitochondrial translational research.
So far, she has published a total of 56 articles (24 as senior author, including contributions in relevant scientific journals like Cell Metabolism, Trends in Biochemical Sciences, EMBO Journal or Cell Reports). She belongs to the Editorial Board of Frontiers in Physiology and Frontiers in Cell and Developmental Biology. Finally, she was a Founder Member of the European Society for Mitochondrial Research and Medicine (E-mit Society, www.emit.org), where she is currently part of the official Executive Board.
Host: Dr. Yolanda Cámara Navarro, Main researcher, Neuromuscular and Mitochondrial Pathology (VHIR)
Registre Online: https://gencat.zoom.us/j/91648965643
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.